Dozens of plaintiffs have filed a joint lawsuit against Gilead in federal court, claiming it failed to adequately warn about the kidney and bone risks linked to its HIV drugs, and withheld safer formulations in order to maximize profits.…
A federal judge will allow a class action lawsuit against Gilead and other drug manufacturers to proceed, which alleges they violated antitrust laws to prevent generic versions of the company’s HIV drugs to hit the market.…
A new study finds that the U.S. pays the most for HIV drugs of any nation, yet falls behind other advanced nations in viral suppression rates.…
A new lawsuit filed by 86 plaintiffs say Gilead knowingly sold highly toxic HIV drugs to consumers, resulting in kidney and bone injuries, knowing it had a safer alternative.…
Gilead and a number of other drug manufacturers face a class action lawsuit from healthcare insurers who say they illegally manipulated HIV drug prices, exposing patients to unnecessarily toxic formulations.…
A new lawsuit filed by a group of plaintiffs claims Gilead allowed patients to take toxic HIV drugs in order to maximize profits, while shelving safer formulations until patent protections ran out.…
Lawsuits allege that side effects of Truvada, Viread, Atripla, Complera and Stribild may have been avoided if the manufacturer had not withheld safer versions of the HIV drugs as part of a scheme to maximize profits.…
A new analysis shows Gilead is rapidly convincing Truvada users to switch over to Descovy before the drug goes generic, amid claims it kept the safer drug shelved for years to maximize profits on the more toxic product.…
A Justice Department lawsuit accuses Gilead of patent infringement in its sale of Truvada and Descovy as HIV prevention drugs.…
An HIV drug lawsuit removed to federal court last week blames the side effects of Atripla and Viread for kidney and bone damage, saying Gilead sat on a safer alternative while failing to warn doctors or patients about the risks.…
